Matching degree between PI3K/AKT/mTOR (PAM) pathway mutations (mut) and therapy (ttx) as predictor of clinical benefit (ClinBen) in early trials
Autor: | Ana Maria Martinez de Castro, Paolo Nuciforo, Irene Brana, Ana Vivancos, Cinta Hierro, Cristina Saura, Ana Oaknin, Jordi Rodon Ahnert, Maria Ochoa de Olza, Rodrigo Dienstmann, Juan Martin Liberal, Analia Azaro, Cristina Cruz Zambrano, Josep Tabernero, Mafalda Oliveira, Helena Aguilar, Guillem Argiles, Elena Sanchez |
---|---|
Rok vydání: | 2016 |
Předmět: | |
Zdroj: | Journal of Clinical Oncology. 34:2572-2572 |
ISSN: | 1527-7755 0732-183X |
Popis: | 2572Background: Drugs targeting aberrations in the PAM pathway are in clinical development but it is not completely clear if mut and ttx matching increases chances of ClinBen. Methods: Retrospectiv... |
Databáze: | OpenAIRE |
Externí odkaz: |